COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

被引：0
|
作者：
Kaczor, M. P. [1 ]
Wojcik, R. [2 ]
Pawlik, D. [2 ]
Skrzekowska-Baran, I [3 ]
Tronczynski, K. [3 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
[2] Aestimo Sc, Krakow, Poland
[3] Janssen Cilag Polska, Warsaw, Poland
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.217
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A359 / A360
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naive chronic hepatitis C genotype 1 patients in Japan
    Kuwabara, Hiroyo
    Westerhout, Kirsten
    Treur, Maarten
    Cerri, Karin
    Mahlich, Joerg
    Yatsuhashi, Hiroshi
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (07) : 502 - 511
  • [2] Cost-Effectiveness Assessment of Telaprevir Combination Treatment Compared to Pegylated-Interferon plus Ribavirin Alone in the Management of Chronic Hepatitis C in Treatment-naive Patients
    Brogan, Anita
    Miller, Jeffrey
    Talbird, Sandra
    Thompson, James
    Deniz, Baris
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S410 - S410
  • [3] COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY
    Stahmeyer, J. T.
    Schauer, S.
    Wirth, D.
    Fleischmann, J.
    Lee, S.
    Gavart, S.
    Bianic, F.
    Cure, S.
    Krauth, C.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A396 - A396
  • [4] COST-EFFECTIVENESS OF TELAPREVIR WITH PEGINTERFERON AND RIBAVIRIN FOR TREATMENT-NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV OF GENOTYPE 1 IN JAPAN
    Ishida, H.
    Terai, S.
    Sakaida, I
    Inoue, Y.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A328 - A328
  • [5] THE COST-EFFECTIVENESS OF TELAPREVIR TRIPLE THERAPY IN TREATMENT OF NAIVE CHRONIC HEPATITIS C PATIENTS IN TURKEY
    Ozdemir, O.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A670 - A670
  • [6] COST-EFFECTIVENESS OF TELAPREVIR PLUS PEGINTERFERON/RIBAVIRIN (TVR plus PR) VERSUS PEGINTERFERON/RIBAVIRIN (PR) IN TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS WITH F2 FIBROSIS IN BRAZIL
    Morais, A. D.
    Pereira, M. L.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A354 - A354
  • [7] Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C
    Brogan, Anita J.
    Talbird, Sandra E.
    Thompson, James R.
    Miller, Jeffrey D.
    Rubin, Jaime
    Deniz, Baris
    [J]. PLOS ONE, 2014, 9 (03):
  • [8] THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS
    Curtis, S.
    Cure, S.
    Gavart, S.
    Dearden, L.
    Fleischmann, J.
    Ouwens, M.
    Lee, S.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S434 - S434
  • [9] Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
    Buti, M
    Casado, MA
    Fosbrook, L
    Wong, JB
    Esteban, R
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (04) : 651 - 658
  • [10] Eruptions in Patients with chronic hepatitis C receiving combination therapy with Telaprevir, Peginterferon and Ribavirin
    Eleftheriadis, V
    Stadler, R.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 869 - 869
12345